About this course

Learning Objectives

• Explain the various layers of psychosis, including its neurobiological, psychological, and sociocultural aspects.
• Plan sessions that focus on building bridges between individuals experiencing psychosis, their families, and healthcare professionals.
• Discuss holistic approaches to the treatment and management of psychosis.

Target Audience

Course Instructor(s)

• 

  Ashley Pena, LCSW

  National Executive Director at Mission Connection

  Ashley is the National Executive Director of Mission Connection, the outpatient extension of AMFM Healthcare’s compassion-driven, evidence-based, clinical program. In her role she oversees a team of clinicians who provide IOP services, both in person and via telehealth. Her leadership skills are focused on compassion, trust, safety, and inclusivity. Being a licensed clinician first, Ashley derives her leadership skills from being a therapist, ensuring connection and understanding of each team member she supports. Ashley ensures that the quality of care at Mission Connection never wavers. Quality of care is of the utmost importance in her role. Some of the core values Ashley focuses on at Mission Connection are innovation, integrative care, compassion, and connection.

  Ashley’s journey in the helping profession began as an ABA therapist. She has gained experience working in non-profit organizations working with foster youth in various settings. Ashley then joined AMFM Healthcare in 2019 as a residential level of care therapist. During her time as a therapist at AMFM, she identified a key area of care that was missing, which was identified as continued care. This led to assisting in developing Mission Connection, outpatient services at AMFM Healthcare.

Disclosure

References

• Lazzari, C., Kotera, Y., & Rabottini, M. (2022). Should mindfulness-based cognitive therapy be used for psychosis? A systematic review of the literature and meta-analysis. Rivista di psichiatria, 57(5), 203-211.
• Sheng, J. L., Yan, Y., Yang, X. H., Yuan, T. F., & Cui, D. H. (2019). The effects of Mindfulness Meditation on hallucination and delusion in severe schizophrenia patients with more than 20 years’ medical history. CNS Neuroscience & Therapeutics, 25(1), 147.
• Vignaud, P., Reilly, K. T., Donde, C., Haesebaert, F., & Brunelin, J. (2019). Clinical effects of mindfulness-based intervention in patients with first episode psychosis and in individuals with ultra-high risk for transition to psychosis: A review. Frontiers in psychiatry, 10, 489084.
• Substance Abuse and Mental Health Services Administration. (2016). Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration (US). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t20/
• Cole, J. C., Bernacki, C. G., Helmer, A., Pinninti, N., & O’reardon, J. P. (2015). Efficacy of transcranial magnetic stimulation (TMS) in the treatment of schizophrenia: a review of the literature to date. Innovations in clinical neuroscience, 12(7-8), 12.
• Brisch, R., Saniotis, A., Wolf, R., Bielau, H., Bernstein, H. G., Steiner, J., ... & Gos, T. (2014). The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Frontiers in psychiatry, 5, 47.
• Neurological, P. (2001). Developmental Disorders: Meeting the challenge in the developing world. Washington (DC).